BioSpace News Archive

Drug Development

ASCO: AstraZeneca Posts Strong Survival Data for Tagrisso in NSCLC Patients

After five years of follow-up, AstraZeneca’s Tagrisso reduces the risk of death by 51% as compared with placebo in EGFR-mutated NSCLC patients, according to Phase III ADAURA trial results.

June 5, 2023
·
2 min read
·
Tristan Manalac
Drug Development

ASCO: AstraZeneca Imfinzi-Lynparza Shows Benefit in Phase III Ovarian Cancer Study

The combination therapy was added to standard chemotherapy and lowered the risk of progression or death by 37% in newly diagnosed patients with advanced ovarian cancer without BRCA mutations.

June 5, 2023
·
2 min read
·
Lisa Munger
Drug Development

ASCO: French Pharma’s Drug Slows Tumors in Brain Cancer Patients

Servier Pharmaceuticals’ Vorasidenib, acquired from Agios in a $1.8 billion deal, slowed the growth of a certain type of low-grade glioma by 61% in a Phase III trial.

June 5, 2023
·
3 min read
·
Heather McKenzie
Drug Development

ASCO: BMS’ Opdivo Challenges Seagen’s Adcetris with Phase III Win

Data from a new head-to-head study showed BMS’ Opdivo induced better progression-free survival among Hodgkin’s lymphoma patients than Seagen’s Adcetris.

June 5, 2023
·
2 min read
·
Tristan Manalac
Drug Development

Akero’s NASH Candidate Clears Phase IIb, Cuts Liver Fat by up to 65%

Non-alcoholic steatohepatitis patients treated with the company’s efruxifermin saw significant improvements in liver fat and biomarkers of liver damage, fibrosis and cardiometabolic health.

June 5, 2023
·
4 min read
·
Tristan Manalac
BioCapital

American Society of Clinical Oncology confers highest honor upon Prof Hagop Kantarjian

Ascentage Pharma announced that its Clinical Advisory Board member Prof Hagop M. Kantarjian has received the David A. Karnofsky Memorial Award for his lifelong contributions to leukemia clinical research and his dedication to improving the lives of patients.

June 5, 2023
·
6 min read
Genetown

ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with Pherecydes

ERYTECH Pharma announced that Akkadian Partners has initiated legal proceedings to obtain the postponement of the vote on the merger with Pherecydes at the Annual General Meeting on June 23.

June 5, 2023
·
1 min read
Business

ANGLE Announces Senior Management Appointments

ANGLE plc, a world-leading liquid biopsy company, is delighted to announce the appointments of Brett Swansiger as Chief Commercial Officer and Karen Miller PhD as Chief Scientific Officer.

June 5, 2023
·
7 min read
Lunit and Capio S:t Göran Hospital Collaborate to Address Radiologist Shortage with AI-Powered Mammography Analysis

Lunit, a leading global provider of AI-powered cancer diagnostic solutions, announced the signing of a supply and license agreement with Capio S:t Göran Hospital, Stockholm, Sweden.

June 5, 2023
·
4 min read
BioInvent to Present at Jefferies Healthcare Conference on June 8

BioInvent International announces it will present the company at the Jefferies Healthcare Conference, taking place June 7-9 in New York.

June 5, 2023
·
2 min read